Federal HIV Budget
To continue progress toward ending the HIV epidemic, each year, the U.S. government invests billions of dollars to support HIV prevention, testing, care and treatment, and research initiatives in the United States.
Congress annually appropriates funds to Departments and agencies across the federal government that are designated to address HIV prevention, care, treatment, and research priorities. Each year, these agencies provide information to Congress and the public about how these dollars are spent. Additional information about the funding discussed below can be found on the budget pages of each agency's website.
Federal Domestic HIV/AIDS Programs & Research Spending
The U.S. government investment in the domestic response to HIV has risen to more than $28 billion per year, including both discretionary and mandatory spending. Discretionary spending levels are determined each year by Congress through the appropriations process.
In contrast, mandatory spending is required by existing laws and not dependent on annual Congressional appropriations. The laws establishing mandatory spending programs set eligibility rules and payment formulas. Mandatory spending includes spending for entitlement programs such as Social Security, Medicare, Medicaid, veterans’ benefits, and certain other payments to people, businesses, and state and local governments. Mandatory spending that supports HIV services includes Medicaid, Medicare, Social Security Disability Insurance (SSDI), Supplemental Security Income (SSI), and a few other programs providing health coverage and cash assistance.
The table below provides an overview of the Congressionally enacted budgets for domestic discretionary spending on HIV services and research in Fiscal Years (FY) 2023-2026 and the President’s budget proposal for FY 2027. The U.S. government fiscal year runs from October 1 to September 30 each year. For information about federal funding supporting the Ending the HIV Epidemic in the U.S. (EHE) initiative, see Ending the HIV Epidemic Funding.
U.S. Federal Domestic Discretionary Funding for HIV/AIDS: FY 2023-2027 (proposed)
(in USD $ Millions)
| Agency/Program | FY 2023 | FY 2024 | FY 2025 | FY 2026 | FY2027 PBR |
|---|---|---|---|---|---|
| AHA-EHE1 | - | - | - | - | $220.00 |
| CDC Domestic HIV Prevention | $1,013.71 | $1,013.71 | $1,013.71 | $1,013.71 | $0.00 |
| EHE portion of total above | $220.00 | $220.00 | $220.00 | $220.00 | $0.00 |
| HRSA Ryan White HIV/AIDS Program1 | $2,571.04 | $2,571.04 | $2,571.04 | $2,571.04 | $2,498.00 |
| ADAP (AIDS Drug Assistance Prog.) portion | $900.30 | $900.30 | $900.30 | $900.30 | $900.30 |
| EHE portion | $165.00 | $165.00 | $165.00 | $165.00 | $165.00 |
| HRSA Health Centers Program (only EHE funds) | $157.25 | $157.25 | $157.25 | $157.25 | $157.25 |
| Indian Health Service (only EHE funds) | $5.00 | $5.00 | $5.00 | $5.00 | $5.00 |
| NIH – AIDS research2 | $3,294.00 | $3,294.00 | $3,288.00 | $3,288.00 | $2,690.00 |
| EHE portion | $26.00 | $26.00 | |||
| SAMHSA (only Minority AIDS Initiative) | $119.31 | $0.00 | $119.31 | $119.31 | $0.00 |
| HHS Office of Infectious Disease & HIV/AIDS Policy1 | $7.58 | $7.58 | $7.58 | $7.58 | |
| HHS Minority HIV/AIDS Fund | $60.00 | $60.00 | $60.00 | $56.00 | $0.00 |
| HUD – Housing Opportunities for Persons With AIDS (HOPWA) | $499.00 | $505.00 | $505.00 | $529.00 | $0.00 |
| Subtotal: HIV Discretionary Spending | $7,719.31 | $7,606.00 | $7,719.31 | $7,739.31 | $6,643.13 |
NOTES:
1. The Administration for a Healthy America (AHA) is a proposed HHS agency and has not previously existed/been funded. In the FY2027 President's Budget proposal, funding for CDC EHE in activities, the Ryan White HIV/AIDS Program, and the HHS Office of Infectious Disease and HIV/AIDS Policy are moved to AHA.
2. The NIH does not define HIV research as “domestic” given its broad application; the figure listed is for all HIV research regardless of whether it is global or domestic.
FY 2027 President’s Budget Request
In addition to the discretionary funding levels indicated in the table above, the President’s FY 2027 budget request also proposes an HHS reorganization that would establish a new operating division within the Department of Health and Human Services, the Administration for a Healthy America (AHA). AHA would serve as the Department’s coordinating platform for prevention, primary care, and community-based health programs, consolidating primary care, environmental health, HIV, maternal and child health, mental and behavioral health, health workforce, programs and activities currently situated in CDC, HRSA, NIH, SAMHSA, OASH.
The FY 2027 President’s Budget notes HIV programs and activities that would be incorporated into AHA include the Ryan White HIV/AIDS Program, CDC’s EHE activity, and the Office of Infectious Disease and HIV/AIDS Policy currently situated in the Office of the Assistant Secretary for Health.
HIV-Related Comorbidities Funding
A strong HIV response also must address the related health conditions that often occur alongside HIV, such as viral hepatitis, sexually transmitted infections, alcohol and substance use disorders, and mental health conditions. Federal agencies that fund work in these areas include the agencies listed in the table above, along with others that support research and programs focused on these comorbidities, including:
- Bureau of Primary Health Care, HRSA
- Department of Veterans Affairs
- Division of Adolescent and School Health, CDC
- Division of STD Prevention, CDC
- Division of Viral Hepatitis, CDC
- Office of Population Affairs, HHS
- Substance Abuse and Mental Health Services Administration, HHS